Tag: ODP

Blue Horseshoe Stocks: VIDG, PBR Calls & More

Vid3G, Inc. VIDG

We’re bringing VIDG up as an item of interest this morning as a stock that is coming off of its 52-week lows, and our subscribers are well aware, we’ve seen plays like these produce exponential gains on the rebound many times in the past.

Yesterday’s session saw a rapid swing up from that annual low (.01), and VIDG managed to break through its 50DMA at .015, as well as maintain that level into the close. Another session of higher highs and higher lows would go a long way toward confirming this uptrend. We’d like to see that previous area of resistance hold as support moving ahead, and based on a number of indicators on the chart, the chance for a bounce to .02 or better is certainly present; VIDG has produced spikes of that magnitude several times this year.

We illustrate this and other points on the chart in the following video, so take a look:

Petroleo Brasiliero S.A. (Petrobras) PBR – Options

On Friday, we mentioned our interest in the PBR $16 Calls for this week, and included a reminder in yesterday morning’s report as well. We’ve become quite adept at playing the PBR options chain over the last several months, and these alerts simply confirm that.

The action on the $16 Weekly Calls indeed proved to be significant as the trading week commenced, with yesterday’s session seeing an intraday move from .20-.38, good for gains of up to 90% A great way to kick things off for these contracts which are now in the money, and we’ll be sticking with the $16’s as the week presses on.

Should PBR approach the 16.35-level, we would then have to consider moving up our strike price.

IsoRay, Inc. ISR

We also want to throw ISR into the mix this morning, as the stock is gapping up off of a relative bottom on some exciting news this morning, so we wanted to enter this into the log as an interesting play that we’re going to want to keep an eye on.

RICHLAND, WA, Aug 05, 2014 (Marketwired via COMTEX) — IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the publication of the first major peer reviewed study showing superior results using IsoRay’s Cesium-131 seeds in the treatment of metastatic brain cancer. >>>FULL PR

Extended Watchlist:
ODP, ESI, GRPN, MNI, KORS

Blue Horseshoe Stocks: ISRG, ANAS & Extended Watchlist

Inuitive Surgical, Inc. ISRG
We’ve got a couple new plays to watch this morning, starting with ISRG, a big-board stock that has us interested in its options chain for potential gains over the next several weeks.

Resistance is sitting at 399.12 (200DMA), a break of which could fill that first gap on the chart. A subsequent break of the 50DMA at 430.27 would mean the likely filling of the second chart gap, which could take it clear to the $480-range.

As a result of current chart conditions, we’re going to radar the June 6th $400 Calls. Those contracts were trading at 3.30 yesterday, and could potentially turn in multi-bag gains provided the stock breaks the areas of resistance we just mentioned. Again, this will be a play that we monitor for an extended time period.

Alternaturals, Inc. ANAS

ANAS popped up on our scanner this morning, and we figured we’d put it on people’s radars in light of several factors. For starters, the news out this morning alludes to forthcoming share reduction efforts by the company, wherein they promise not to use a reverse split as they attempt to clean up the share structure.

The PR goes on to state the company’s intent to move forward, either through an eventual exchange uplisting or potential buyout scenario. Those are interesting claims, and we’ll be anxious to follow this storyline to see if management makes good on those aspirations.

We’re going to be monitoring ANAS as it searches for support, and putting this play on bottom watch. The stock has been under consolidation since a recent run-up, so we’ll be looking to take advantage of any forthcoming bounceplay opportunities.

GRANDVILLE, Mich., May 6, 2014 /PRNewswire via COMTEX/ — Alternaturals, Inc. (OTCPink : ANAS) today announced that it has plans to begin buying back shares in the open market in order to increase shareholder value and position the company as either a favorable acquisition target, or for listing on a reporting market in the future. However, senior management vows not to reverse split the company.The company wants to make sure that the share structure is attractive to larger firms looking for an acquisition, in the event that becomes the best route to take. The company also wants to be ready for listing on a fully reporting market by the end of the year as a longer-term plan. >> FULL PR

Extended Watchlist:
ODP, FST, AKS, LIVE,

CHGS, DUSS & Extended Watchlist

China GengSheng Minerals, Inc. CHGS
–
After appearing on yesterday morning’s extended watchlist, CHGS came screaming out of the gate, running from .19 all the way up to .35 (+84%). The stock consolidated, and followed that initial run with two subsequent bounces, one from .24-.35 (+46%), and another from .28 to the day’s high at .39 (+39%).

A tip of the cap to anyone who was able to take advantage of some of the nearly 170% in cumulative intraday gains provided by CHGS, which can be seen on the following chart:

Dussault Apparel, Inc. DUSS
DUSS was the addition we made to the day’s watchlist in yesterday’s afternoon update. Following that alert, we saw a low of .0012, followed by a 25% run-up to the .0015 high-of-day where the stock closed.

As you can see on the annotated chart below, the next key area of resistance to watch for a break resides at .0024. A break past that point would put us in blue-sky breakout territory.

PLEASE NOTE: DUSS is a play that we selected from one of our daily scans. We were not compensated in any way to feature DUSS in our reports, however, owners of this newsletter did purchase two million (2,000,000) shares out of the open market.

Extended Watchlist:
KERX, GERN, ODP, BORN, FB, AAPL, XNY, RMTI